Gilead to Launch Generics for Its Hepatitis C Drugs By Sam | September 25, 2018 Against a backdrop of declining sales for its branded hepatitis drugs, Gilead announced plans to launch its own “authorized generics” of two of its hep C treatments. Source: Drug Industry Daily Posted in Drug Industry Daily